URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of April 15, 2015 concerning a ibuprofen and risk of cardiovascular events large doses of the medicinal product
16.04.2015
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of April 15, 2015 concerning a ibuprofen and risk of cardiovascular events large doses of the medicinal product.
SciencePharma
